These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 15225011)

  • 21. [Prevention of thromboembolism following heart valve replacement].
    van de Loo J; Stenzinger W
    Verh Dtsch Ges Inn Med; 1989; 95():275-82. PubMed ID: 2690497
    [No Abstract]   [Full Text] [Related]  

  • 22. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total preservation of subvalvular apparatus during mitral valve replacement.
    Mediratta N; Sosnowski AW
    Ann Thorac Surg; 1998 Jun; 65(6):1840-1. PubMed ID: 9647131
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute thrombotic obstruction of mitral valve prosthesis: low protein C level.
    Ohata T; Sakakibara T; Takano H; Ishizaka T
    Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):165-6. PubMed ID: 12079945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitral valve repair versus replacement in simultaneous mitral and aortic valve surgery for rheumatic disease.
    Kuwaki K; Kawaharada N; Morishita K; Koyanagi T; Osawa H; Maeda T; Higami T
    Ann Thorac Surg; 2007 Feb; 83(2):558-63. PubMed ID: 17257987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of thrombosis and thromboembolism after mitral valve bioprosthesis].
    Malinovskiĭ NN; Konstantinov BA; Cherepenin LP; Dzemeshkevich SL; Ivanov AS
    Khirurgiia (Mosk); 1982 Nov; (11):64-8. PubMed ID: 7176405
    [No Abstract]   [Full Text] [Related]  

  • 27. Thromboembolic risk and durability of the Hancock bioprosthetic cardiac valve.
    Oyer PE; Stinson EB; Miller DC; Jamieson SW; Mitchell RS; Shumway NE
    Eur Heart J; 1984 Oct; 5 Suppl D():81-5. PubMed ID: 6519106
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
    Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early failure of bioprostheses caused by adhesion of preserved leaflets after chordal-sparing mitral valve replacement.
    Robertson JO; Durrani AK; Mihaljevic T
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1180-1. PubMed ID: 18455607
    [No Abstract]   [Full Text] [Related]  

  • 30. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
    Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thromboembolic complications following mitral prosthesis implantation].
    Gawdziński M
    Pol Tyg Lek; 1977 Jan; 32(2):49-52. PubMed ID: 834633
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mitral valve substitution with a dura mater valve].
    Morillo F; Fiz L; Paravisini J
    Rev Esp Cardiol; 1979; 32(1):51-6. PubMed ID: 441486
    [No Abstract]   [Full Text] [Related]  

  • 33. Mid-term results after Epic xenograft implantation for aortic, mitral, and double valve replacement.
    Lehmann S; Walther T; Leontjev S; Kempfert J; Rastan A; Garbade J; Borger MA; Falk V; Mohr FW
    J Heart Valve Dis; 2007 Nov; 16(6):641-8; discussion 648. PubMed ID: 18095514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of thromboembolism in heart valve diseases and following heart valve replacement].
    Stenzinger W; van de Loo J
    Internist (Berl); 1989 Aug; 30(8):520-4. PubMed ID: 2676892
    [No Abstract]   [Full Text] [Related]  

  • 35. Valvular replacement in a pediatric population: an Italian multicenter study.
    Gargiulo G; Arciprete P; Abbruzzese P; Crupi G; Di Donato R; Mignosa C; Murzi B; Pomè G; Stellin G; Vosa C; Zannini L
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S84-5. PubMed ID: 15225012
    [No Abstract]   [Full Text] [Related]  

  • 36. Mitral valve apparatus preservation and early bioprosthetic thrombosis: a word of caution.
    Evora PR; Basseto S; Alves Junior L; Rodrigues AJ
    Arq Bras Cardiol; 2011 May; 96(5):e98-9. PubMed ID: 21603797
    [No Abstract]   [Full Text] [Related]  

  • 37. Is early antithrombotic therapy necessary in bioprosthetic valves?
    Mestres CA; Aramendi JI
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):724-5; author reply 725-6. PubMed ID: 20723739
    [No Abstract]   [Full Text] [Related]  

  • 38. Replacement of heart valves by prosthetic devices.
    Byrne JP; Behrendt DM; Kirsh MM; Orringer MB
    Pathobiol Annu; 1977; 7():83-114. PubMed ID: 339155
    [No Abstract]   [Full Text] [Related]  

  • 39. Searching for the truth: a mechanical or a tissue valve?
    Phillips SJ
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S95-8. PubMed ID: 15225017
    [No Abstract]   [Full Text] [Related]  

  • 40. Choosing the most appropriate valve operation and prosthesis.
    Thamilarasan M; Griffin B
    Cleve Clin J Med; 2002 Sep; 69(9):688-90, 693-4, 696-8 passim. PubMed ID: 12222973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.